These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12625994)

  • 1. A case series of eight aggressive young children treated with risperidone.
    Cesena M; Gonzalez-Heydrich J; Szigethy E; Kohlenberg TM; DeMaso DR
    J Child Adolesc Psychopharmacol; 2002; 12(4):337-45. PubMed ID: 12625994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone for young children with mood disorders and aggressive behavior.
    Schreier HA
    J Child Adolesc Psychopharmacol; 1998; 8(1):49-59. PubMed ID: 9639079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Clin Psychiatry; 2003 Sep; 64(9):1039-47. PubMed ID: 14628979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review.
    Frazier JA; Meyer MC; Biederman J; Wozniak J; Wilens TE; Spencer TJ; Kim GS; Shapiro S
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):960-5. PubMed ID: 10434487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder.
    Pavuluri MN; Henry DB; Carbray JA; Sampson GA; Naylor MW; Janicak PG
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):336-50. PubMed ID: 16768641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series.
    Gonzalez-Heydrich J; Pandina GJ; Fleisher CA; Hsin O; Raches D; Bourgeois BF; Biederman J
    J Child Adolesc Psychopharmacol; 2004; 14(2):295-310. PubMed ID: 15319026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin levels in young children with pervasive developmental disorders during risperidone treatment.
    Masi G; Cosenza A; Mucci M
    J Child Adolesc Psychopharmacol; 2001; 11(4):389-94. PubMed ID: 11838821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.
    Klampfl K; Taurines R; Preuss A; Burger R; Rothenhöfer S; Wewetzer Ch; Pfuhlmann B; Fegert J; Gerlach M; Mehler-Wex C
    Pharmacopsychiatry; 2010 Mar; 43(2):58-65. PubMed ID: 20336598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
    Van Bellinghen M; De Troch C
    J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.
    Kalkan Ucar S; Ozbaran B; Demiral N; Yuncu Z; Erermis S; Coker M
    Brain Dev; 2010 Feb; 32(2):156-61. PubMed ID: 19217229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial of risperidone in 24 young children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1206-14. PubMed ID: 11589534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
    Luby J; Mrakotsky C; Stalets MM; Belden A; Heffelfinger A; Williams M; Spitznagel E
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):575-87. PubMed ID: 17069546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
    Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
    J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.